NOVEL DRUGS IN FOLLICULAR LYMPHOMA by Giuseppe Rossi, Antonella Anastasia

Subjects: “…Follicular Lymphoma, New Drugs, Therapy…”
Get full text

Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho by Lawrence Oyewusi, Chengbo Zeng, KJ Seung, Stephanie Mpinda, Mikanda Kunda, Carole D Mitnick, Makelele Kanu, Meseret Tamirat, Joalane Makaka, Mabatloung Mofolo, Refiloe Maime, Llang Maama, Ninza Senyo, Bamidele Oguntoyinbo, Lwayi Mayombo, Molly F Franke

Subjects: Get full text

THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT by Anuj Mahindra, Jacob Laubach, Paul Richardson, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson

Subjects: “…Myeloma,New Drugs, Older People, Bortezomid, Thalidomide, Revlimid…”
Get full text

Editorial: Utilizing omics strategies to discover new drug targets for cancers by Shujun Zhang, Chen Xue, Xinyu Gu

Subjects: Get full text

THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT by Paul Richardson, Jacob Laubach, Anuj Mahindra, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson

Subjects: “…Myeloma,New Drugs, Older People, Bortezomid, Thalidomide, Revlimid…”
Get full text

The Combination of Buparvaquone and ELQ316 Exhibit a Stronger Effect than ELQ316 and Imidocarb Against <i>Babesia bovis</i> In Vitro by Natalia M. Cardillo, Nicolas F. Villarino, Paul A. Lacy, Michael K. Riscoe, Joseph Stone Doggett, Massaro W. Ueti, Chungwon J. Chung, Carlos E. Suarez

Subjects: Get full text

Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists by Monica Carpenedo, Arianna Zappaterra, Beatrice Ferrari, Giulia Cotilli

Subjects: Get full text

Affordable mRNA Novel Proteins, Recombinant Protein Conversions, and Biosimilars—Advice to Developers and Regulatory Agencies by Sarfaraz K. Niazi

Subjects: Get full text

APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA by Tadeusz Robak

Subjects: “…Chronic Lymphoid Leukemia, New Drugs, nucleoside analogs, Flavopiridol, lenalidomide, rituximab, Anti-CD23…”
Get full text

APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA by Tadeusz Robak

Subjects: “…Chronic Lymphoid Leukemia, New Drugs, nucleoside analogs, Flavopiridol, lenalidomide, rituximab, Anti-CD23…”
Get full text

Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity by Jaeseong Oh, Sojeong Yi, Namyi Gu, Dongseong Shin, Kyung-Sang Yu, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang

Subjects: Get full text

FingerDTA: A Fingerprint-Embedding Framework for Drug-Target Binding Affinity Prediction by Xuekai Zhu, Juan Liu, Jian Zhang, Zhihui Yang, Feng Yang, Xiaolei Zhang

Subjects: Get full text